Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial

医学 射频消融术 肝细胞癌 优势比 放射科 外科 米兰标准 烧蚀 内科学 导管消融
作者
Dong Ho Lee,Min Woo Lee,Pyo Nyun Kim,Young Joon Lee,Hee Sun Park,Jeong Min Lee
出处
期刊:Radiology [Radiological Society of North America]
卷期号:301 (1): 229-236 被引量:9
标识
DOI:10.1148/radiol.2021210309
摘要

Background Recently introduced no-touch radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC) has the potential to improve local tumor control. Purpose To evaluate midterm clinical outcomes of monopolar no-touch RFA in single HCCs 2.5 cm or smaller. Materials and Methods In this multicenter clinical trial (ClinicalTrials.gov: NCT03375281), participants were evaluated for eligibility from November 2017 to January 2019. Patients with single HCCs 2.5 cm or smaller planning to be treated with no-touch RFA were enrolled. The rate of successful no-touch RFA, defined as performing RFA without violation of the tumor itself, was recorded. Multivariable logistic regression analysis was used to determine associated factors for failure of no-touch RFA. Development of major complication after no-touch RFA was also recorded. Cumulative incidence of local tumor progression (LTP) and recurrence-free survival were estimated by using the Kaplan-Meier method. Results A total of 140 participants (mean age, 62 years ± 9 [standard deviation]; 106 men) were evaluated. No-touch RFA was successfully performed in 128 participants (128 of 140; 91.4%), and conversion to tumor puncture RFA was undertaken in 12 participants because of the lack of a safe access route. By using either no-touch RFA or conversion to tumor puncture RFA, all participants achieved technical success of RFA, which was defined as complete coverage of target tumor by ablation zone. Insufficient peritumoral parenchyma (<5 mm width around more than half portion of tumor; odds ratio, 74; 95% CI: 18, 309; P < .001) was the only significant predictive factor for failure of the no-touch technique. Among the 140 participants, LTP developed in two participants, and the estimated 1- and 2-year cumulative incidence of LTP was 0.7% and 1.6%, respectively. The estimated 1- and 2-year recurrence-free survival was 82.8% and 74.1%, respectively. Conclusion No-touch radiofrequency ablation was an effective and safe treatment method for small hepatocellular carcinomas (≤2.5 cm), with 1.6% of cumulative incidence of local tumor progression at 2 years. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Soulen and García-Mónaco in this issue.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
单纯的冬灵完成签到 ,获得积分10
1秒前
3秒前
4秒前
肥猫发布了新的文献求助10
4秒前
4秒前
可爱的函函应助过氧化氢采纳,获得30
7秒前
7秒前
锦鲤完成签到 ,获得积分10
8秒前
任性的白玉完成签到 ,获得积分10
8秒前
youwenjing11发布了新的文献求助10
9秒前
山谷完成签到 ,获得积分10
9秒前
钱宇成发布了新的文献求助10
10秒前
科研通AI2S应助感动黄豆采纳,获得10
14秒前
18秒前
19秒前
22秒前
Fengliguantou发布了新的文献求助10
22秒前
猪猪hero发布了新的文献求助10
24秒前
Winner发布了新的文献求助10
26秒前
隐形曼青应助科研通管家采纳,获得10
26秒前
领导范儿应助科研通管家采纳,获得10
26秒前
Lucas应助科研通管家采纳,获得30
27秒前
27秒前
圆锥香蕉应助科研通管家采纳,获得20
27秒前
科研通AI2S应助科研通管家采纳,获得10
27秒前
科研通AI2S应助科研通管家采纳,获得10
27秒前
科目三应助科研通管家采纳,获得10
27秒前
充电宝应助科研通管家采纳,获得10
27秒前
脑洞疼应助科研通管家采纳,获得10
27秒前
科研通AI5应助科研通管家采纳,获得10
27秒前
852应助科研通管家采纳,获得10
27秒前
科研通AI2S应助科研通管家采纳,获得10
27秒前
科研通AI2S应助科研通管家采纳,获得10
27秒前
情怀应助科研通管家采纳,获得10
28秒前
28秒前
感动黄豆发布了新的文献求助10
28秒前
31秒前
搞怪冷风完成签到,获得积分10
32秒前
lucky完成签到,获得积分10
32秒前
量子星尘发布了新的文献求助10
33秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989115
求助须知:如何正确求助?哪些是违规求助? 3531367
关于积分的说明 11253688
捐赠科研通 3269986
什么是DOI,文献DOI怎么找? 1804868
邀请新用户注册赠送积分活动 882078
科研通“疑难数据库(出版商)”最低求助积分说明 809105